PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-06-06

Date Title Company
06-Jun-2024 Board-Certified and Highly Accomplished Lasik Surgeon Now Treating Patients at Lasikplus Houston AccessWire
06-Jun-2024 Biomedical Scientists Benefit NHS Up to £571M in Bowel Cancer Care The Institute of Biomedical Science (IBMS)
06-Jun-2024 Major cause of inflammatory bowel disease discovered The Francis Crick Institute
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 PM Society Digital Awards – 12th September 2024 - Tickets Now on Sale! PM Society
06-Jun-2024 Global Glass Bottles Market Expected to Reach US$ 70.2 Billion by 2033, Reports Future Market Insights MARKITWIRED
06-Jun-2024 The exercise period for Moberg Pharma's warrants of series 2023:1 (TO 2) begins today Moberg Pharma
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 Lifeskills South Florida Expands Mental Health and Addiction Treatment Services to Orlando, Florida AccessWire
06-Jun-2024 Global Passive Temperature-Controlled Packaging Market to Sizzle at 9.1% CAGR Through 2031 | FMI MARKITWIRED
06-Jun-2024 Original-Research: M1 Kliniken AG (von First Berlin Equity Research GmbH) M1 Kliniken AG
06-Jun-2024 Biotricity Provides Year-End Guidance with Expectations to Meet Analyst Revenue Target and Beating Loss and Margin Targets AccessWire
06-Jun-2024 DirectTrust(R) and Digital Therapeutics Alliance Announce Partnership to Provide Accreditation for Digital Therapeutics Industry AccessWire
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 Alchemab advances a novel antibody with potential in Parkinson’s disease with support from The Michael J. Fox Foundation Alchemab
06-Jun-2024 Vapourtec launches compact and flexible Peptide-ExplorerLT synthesiser Vapourtec
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
06-Jun-2024 Cloud DX Inc. Announces Restructuring Process and the Resignation of 2 Directors AccessWire
06-Jun-2024 Ensysce Biosciences Announces Major Milestone for Opioid Use Disorder Program AccessWire
06-Jun-2024 Theralase(R) Successfully Destroys Lung Cancer AccessWire